Douglas B. Given, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 68,000 shares at $18.05 ($1.3M) on 2019-02-22, disclosed to the SEC on 2019-02-26.
Open-market sale of $1.3M ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.05 | 3,000 | $54K | 4.1% |
| 2 | $19.25 | 65,000 | $1.3M | 95.9% |
| Total | $19.20 avg | 68,000 | $1.3M | 100% |
| Filing → |
| ARWR | SELL | 2023-05-08 | $266K | — | Filing → |
| ARWR | SELL | 2023-03-01 | $29K | — | Filing → |
| ARWR | BUY | 2021-12-29 | $43K | — | Filing → |